Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126135911 | 12613591 | 1 | I | 20160710 | 0 | 20160801 | 20160801 | DIR | 56.00 | YR | F | N | 143.00000 | LBS | 20160731 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126135911 | 12613591 | 1 | PS | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Oral | 7 CAPSULE(S) ONCE A DAY TAKEN BY MOUTH | N | D | C601237 | 20180131 | 0 | 7 | DF | CAPSULE | QD | ||
| 126135911 | 12613591 | 3 | C | DIFLUCAN | FLUCONAZOLE | 1 | 0 | ||||||||||||
| 126135911 | 12613591 | 5 | C | CELEBREX | CELECOXIB | 1 | 0 | ||||||||||||
| 126135911 | 12613591 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
| 126135911 | 12613591 | 9 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 126135911 | 12613591 | 11 | C | MIRTAZIPINE | MIRTAZAPINE | 1 | 0 | ||||||||||||
| 126135911 | 12613591 | 13 | C | BUPROPION. | BUPROPION | 1 | 0 | ||||||||||||
| 126135911 | 12613591 | 15 | C | EVOXAC | CEVIMELINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126135911 | 12613591 | 17 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 126135911 | 12613591 | 19 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | 0 | ||||||||||||
| 126135911 | 12613591 | 21 | C | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126135911 | 12613591 | 23 | C | CLONAZAPINE, USP ODT (CLOZAPINE, USP) OCT) (ORAL DISINTEGRATING TABLET) | CLOZAPINE | 1 | 0 | ||||||||||||
| 126135911 | 12613591 | 25 | C | OXYCODONE WITH ACETAMINOPHEN | 2 | 0 | |||||||||||||
| 126135911 | 12613591 | 27 | C | FLORCET | 2 | 0 | |||||||||||||
| 126135911 | 12613591 | 29 | C | ORPHENADRINE | ORPHENADRINE | 1 | 0 | ||||||||||||
| 126135911 | 12613591 | 31 | C | VITAMIN B (MULTI) | 2 | 0 | |||||||||||||
| 126135911 | 12613591 | 33 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126135911 | 12613591 | 35 | C | MULTIVITAMIN | VITAMINS | 1 | 0 | ||||||||||||
| 126135911 | 12613591 | 37 | C | MAGNESIUM | MAGNESIUM | 1 | 0 | ||||||||||||
| 126135911 | 12613591 | 39 | C | BIOTIN | BIOTIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126135911 | 12613591 | 1 | Urinary tract infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126135911 | 12613591 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126135911 | 12613591 | Arthralgia | |
| 126135911 | 12613591 | Gait disturbance | |
| 126135911 | 12613591 | Musculoskeletal stiffness | |
| 126135911 | 12613591 | Pain | |
| 126135911 | 12613591 | Tendon pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126135911 | 12613591 | 1 | 20160706 | 20160712 | 0 |